Induction of oral tolerance in bone marrow transplantation recipients suppresses graft-versus-host disease in a semiallogeneic mouse model

A. Nagler, M. Ohana, R. Alper, V. Doviner, Y. Sherman, E. Rabbani, D. Engelhardt, Y. Ilan*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Graft-versus-host disease (GVHD) is the major obstacle for successful allogeneic stem cell transplantation (SCT). Morbidity and mortality are high, and novel therapeutic strategies are required. Current therapy, which is based mainly on immunosuppression, is associated with a high degree of complications. Immune hyporesponsiveness induced by oral antigen administration has recently been shown to prevent the development of chronic GVHD (cGVHD) in a murine model. The aim of the present study was to evaluate whether it is possible to induce tolerance and to alleviate GVHD in a semiallogeneic transplantation model in mice. GVHD was generated by infusing 2 × 107 splenocytes from C57BL/6 donor mice into (C57BL/6 × Balb/c)F1 recipient mice, which received 7 Gy 60Co total body irradiation (TBI) prior to transplantation. Oral tolerance was induced by feeding recipient F1 mice with five oral doses of proteins, 50 μg/mouse, extracted from C57BL/6 splenocytes on alternate days following transplantation. In vitro mixed lymphocyte reaction (MLR) from tolerized and nontolerized mice was performed. Recipient mice were followed for chimerism, and for clinical and histological parameters of GVHD. Induction of tolerance was documented by a significant reduction in MLR response of tolerated vs nontolerated splenocytes. A significant alleviation of the clinical and pathological manifestation of GVHD was observed in the liver, small bowel, and skin. Tolerance induction did not jeopardize engraftment. These results may constitute a step towards reducing the frequency of GVHD via manipulation of the immune system.

Original languageEnglish
Pages (from-to)363-369
Number of pages7
JournalBone Marrow Transplantation
Volume32
Issue number4
DOIs
StatePublished - Aug 2003
Externally publishedYes

Funding

FundersFunder number
Roaman-Epstein Liver Research Foundation
Israel Cancer Research Fund
Israel Cancer Association

    Keywords

    • GVHD
    • Immune tolerance
    • Oral tolerance

    Fingerprint

    Dive into the research topics of 'Induction of oral tolerance in bone marrow transplantation recipients suppresses graft-versus-host disease in a semiallogeneic mouse model'. Together they form a unique fingerprint.

    Cite this